Companies: 10,795·Total market cap: $144.5T
Compugen Ltd.

Compugen Ltd.

CGENNASDAQHealthcare● Active
$2.04
$-0.06(-2.86%)
Market Cap$192888528
P/E Ratio
52W High$3.24
52W Low$1.3
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Compugen Ltd. (CGEN) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001119774 · CGEN · NASDAQ · as of Jun 9, 2026

Filing snapshot

585
Total Filings
F-3
Latest Form
2026-05-18
Most Recent
2000
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001119774 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-03-02
Fiscal Year End
Mar 2, 2026
Accession No.
0001178913-26-000663
Primary Document
zk2634416.htm
Source: data.sec.gov · CIK 0001119774 · Accession 0001178913-26-000663

Latest Key Filings

6-KQuarterly Report
ZK2635352
2026-05-18
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
F-3F-3
F-3
2026-05-18
View
6-KCurrent Report (Foreign Issuer)
ZK2635352
2026-05-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
Showing 1–15 of 568 filingsForm 4 / 144 hidden· 585 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001119774  |  Exchange: NASDAQ · Healthcare

Compugen Ltd. (NASDAQ: CGEN) has submitted 585 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2000. As a Healthcare sector company with CIK 0001119774, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Compugen Ltd.'s most comprehensive regulatory disclosure. The most recent Compugen Ltd. 10-K was filed on 2026-03-02 for fiscal year ending 2026. Historical CGEN 10-K annual reports are available from 2001 through 2026.

Investors researching Compugen Ltd. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09

Frequently Asked Questions

CGEN SEC Filings · 8 questions

Compugen Ltd. (CGEN) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 585 filings and access original documents at no cost. Compugen Ltd.'s CIK is 0001119774.

CGEN SEC filingsCompugen Ltd. SEC documentsfind CGEN 10-K